The CRISPR genomic cure market is estimated to be valued at US$ 1.84 billion in 2023 and is expected to exhibit a CAGR of 34.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and the Cas system is a bacterial genome-editing tool that can cure genetic diseases by precisely editing genes. CRISPR technology allows precise and permanent ... Read more

The CRISPR-genomic cure market involves the development of therapies and drugs that use CRISPR-Cas genome editing technology to cure complex diseases by modifying the human genome. CRISPR-based therapies hold promise for treating various genetic disorders by precisely editing DNA at the sites of defective genes. The technology allows corrections to be made directly in a patient's cells and tissue, offering potential cures.

The global Crispr Genomic Cure Market is estimated to be ... Read more